|
ES2334953T3
(es)
|
1995-06-28 |
2010-03-17 |
Imperial Cancer Research Technology Limited |
Secuencias de nucleotidos y proteinas de genes delta de vertebrados y metodos basados en los mismos.
|
|
US5780300A
(en)
*
|
1995-09-29 |
1998-07-14 |
Yale University |
Manipulation of non-terminally differentiated cells using the notch pathway
|
|
GB9824045D0
(en)
*
|
1998-11-03 |
1998-12-30 |
European Molecular Biology Lab Embl |
Regulator protein
|
|
GB9827604D0
(en)
*
|
1998-12-15 |
1999-02-10 |
Lorantis Ltd |
Methods of immunosuppression
|
|
GB9927328D0
(en)
*
|
1999-11-18 |
2000-01-12 |
Lorantis Ltd |
Immunotherapy
|
|
GB0019242D0
(en)
*
|
2000-08-04 |
2000-09-27 |
Lorantis Ltd |
Assay
|
|
WO2002024221A2
(en)
|
2000-09-22 |
2002-03-28 |
Genentech, Inc. |
Notch receptor agonists and uses
|
|
US6689744B2
(en)
|
2000-09-22 |
2004-02-10 |
Genentech, Inc. |
Notch receptor agonists and uses
|
|
RU2179862C1
(ru)
*
|
2000-12-26 |
2002-02-27 |
Общество с ограниченной ответственностью Научно-производственный центр "МедБиоСпектр" |
Лекарственное средство для предотвращения отторжения трансплантата, моноклональное антитело к cd3-антигену т-лимфоцитов человека, гибридома и способ лечения больных, имеющих реакцию острого отторжения трансплантата после пересадки почки
|
|
EP1409005A1
(en)
*
|
2001-07-25 |
2004-04-21 |
Lorantis Limited |
Modulators of notch signalling for use in immunotherapy
|
|
GB0118155D0
(en)
*
|
2001-07-25 |
2001-09-19 |
Lorantis Ltd |
Superantigen
|
|
GB0123379D0
(en)
*
|
2001-09-28 |
2001-11-21 |
Lorantis Ltd |
Modulators
|
|
US7682825B2
(en)
*
|
2002-02-06 |
2010-03-23 |
Sanbio, Inc. |
Differentiation of bone marrow stromal cells to neural cells or skeletal muscle cells by introduction of notch gene
|
|
EP1492816A2
(en)
*
|
2002-04-05 |
2005-01-05 |
Lorantis Limited |
Modulators of the notch signalling pathway and uses thereof in medical treatment
|
|
JP2006513260A
(ja)
*
|
2002-08-03 |
2006-04-20 |
ロランティス リミテッド |
Ｎｏｔｃｈシグナル伝達経路調節因子の複合体およびその薬物治療への使用
|
|
GB0218879D0
(en)
*
|
2002-08-14 |
2002-09-25 |
Lorantis Ltd |
Medical treatment
|
|
GB0220658D0
(en)
*
|
2002-09-05 |
2002-10-16 |
Lorantis Ltd |
Immunotherapy
|
|
JP2006513153A
(ja)
*
|
2002-10-09 |
2006-04-20 |
ロランティス リミテッド |
免疫機能の調節
|
|
WO2004060262A2
(en)
*
|
2003-01-07 |
2004-07-22 |
Lorantis Limited |
Modulators of notch signalling for use in immunotherpapy
|
|
GB0300428D0
(en)
*
|
2003-01-09 |
2003-02-05 |
Lorantis Ltd |
Medical treatment
|
|
WO2004064863A1
(en)
*
|
2003-01-23 |
2004-08-05 |
Lorantis Limited |
Treatment of autoimmune diseases using an activator for the notch signaling pathway
|
|
GB0303663D0
(en)
*
|
2003-02-18 |
2003-03-19 |
Lorantis Ltd |
Assays and medical treatments
|
|
ATE474593T1
(de)
*
|
2003-03-21 |
2010-08-15 |
Celldex Therapeutics Ltd |
Behandlung von allergischen erkrankungen unter verwendung eines modulators des notch signaling pathway
|
|
WO2004083372A2
(en)
*
|
2003-03-21 |
2004-09-30 |
Lorantis Limited |
Modulators of the notch signaling pathway immobilized on particles for modifying immune responses
|
|
GB0307472D0
(en)
*
|
2003-04-01 |
2003-05-07 |
Lorantis Ltd |
Medical treatment
|
|
PL2032166T3
(pl)
|
2006-06-13 |
2013-09-30 |
Oncomed Pharm Inc |
Kompozycje i sposoby diagnozowania i leczenia nowotworów
|
|
AU2008209482B2
(en)
|
2007-01-24 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
NZ590127A
(en)
|
2008-07-08 |
2012-11-30 |
Oncomed Pharm Inc |
Notch1 receptor binding agents and methods of use thereof
|
|
BRPI0912912A2
(pt)
*
|
2008-08-22 |
2016-07-05 |
Univ Columbia |
proteína de fusão, método para tratar um indivíduo que tem um tumor, método para inibir a angiogênese em um indivíduo, método para tratar um indivíduo que tem câncer de ovário, método para tratar um indivíduo que tem distúrbio metabólico, uso da proteína de fusão, método para inibir linfangiogênese fisiológica ou linfangiogênese patológica em um indivíduo, método para inibir metástase tumoral em um indivíduo, método para inibir o crescimento de um tumor secundário em um indivíduo, método para inibir a cooptação de um vaso sanguíneo por um tumor em um indivíduo, método para tratar câncer de mama de um indivíduo
|
|
DE112010000371A5
(de)
|
2009-02-16 |
2012-09-06 |
Deutsches Rheuma-Forschungszentrum Berlin |
Verwendung von Notch-Regulatoren zur Modulation der Immunantwort durch Induktion/Suppression von Interleukin-22
|
|
WO2011025964A2
(en)
|
2009-08-29 |
2011-03-03 |
Abbott Laboratories |
Therapeutic dll4 binding proteins
|
|
UA112743C2
(uk)
|
2010-03-02 |
2016-10-25 |
Еббві Інк. |
Терапевтичний dll4-зв'язувальний білок
|
|
CA2832356C
(en)
*
|
2011-04-06 |
2017-12-19 |
Sanbio, Inc. |
Methods and compositions for modulating peripheral immune function
|
|
AU2012339681A1
(en)
*
|
2011-11-16 |
2014-06-19 |
Oncomed Pharmaceuticals, Inc. |
Human NOTCH receptor mutations and their use
|
|
US20150140043A1
(en)
*
|
2012-05-10 |
2015-05-21 |
Institut National De La Sante De La Recherche Medical (Inserm) |
Immunomodulatory methods using notch agonists
|
|
KR101573650B1
(ko)
*
|
2015-02-04 |
2015-12-01 |
성균관대학교산학협력단 |
Hcmv 바이러스 복제 억제용 조성물
|
|
SG11202101455TA
(en)
*
|
2018-08-28 |
2021-03-30 |
Hutchinson Fred Cancer Res |
Methods and compositions for adoptive t cell therapy incorporating induced notch signaling
|